Lumos CEO, Doug Ward, Chief Financial Officer, Barrie Lambert, and Senior VP Commercial Operations, Paul Kase present an overview of the Company‘s outstanding FY24 results and recent progress.
Take a look:
Company News
Video | Q4 FY24 Investor webinar
01 Aug 2024
Keep reading
More news & media.
A few more pieces along the same thread. See the full index for everything.
COMPANY NEWS
1 min read
MST Access research report
MST Access has published a research report on Lumos Diagnostics Limited.
LD
Lumos Diagnostics Communications
Written with AI assistance
COMPANY NEWS
2 min read
FebriDx® Commercial Traction Continues to Advance
Lumos Diagnostics has announced further progress in the U.S. commercialisation of FebriDx® across its priority top-100 urgent care target list.
LD
Lumos Diagnostics Communications
Written with AI assistance
COMPANY NEWS
1 min read
REPLAY | FebriDx US Launch Update
Lumos CEO Doug Ward, Lumos Chief Commercial Officer Paul Kase, Lumos Director of U.S. Sales
LD
Lumos Diagnostics Communications
Written with AI assistance